Using our patented machine-learning drug discovery platform, we have identified under-appreciated proteins integral to maintaining cellular balance and healthy neuronal signalling across key areas of the brain responsible for a range of neurological disorders. Our world class medicinal chemists have engineered and tested small molecule therapies that demonstrate pre-clinical efficacy for terminating epileptic seizures and neuroenhancement.

Stream Neuroscience was co-founded by Dr. Jong Rho, a pediatric epileptologist and a leading expert on the role of mitochondrial function in brain disorders, and Dr. Deborah Kurrasch, a tenured professor and world-renowned expert in neuropharmacology and disease modeling. Incorporated in 2014 and actively commercializing since 2018, Stream Neuroscience has raised nearly $3,000,000 USD in seed finding, with an additional >$5,000,000 USD in non-dilutive funding.